NASDAQ · Medical - Devices
OrthoPediatrics Corp. (KIDS) Stock
$21.76
-3.20%
NASDAQ: KIDS
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Truist Securities Adjusts Price Target on OrthoPediatrics to $20 From $17, Maintains Hold Rating
MT Newswires · Jul 16, 2026
OrthoPediatrics (KIDS) Stock Sees Split Analyst Revisions After Mixed Price Target Changes
Simply Wall St. · Jun 25, 2026
OrthoPediatrics Signs Distribution Deal to Provide Hospitals With OSSIO's Fixation Technology
MT Newswires · Jun 24, 2026
OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals Nationwide
GlobeNewswire · Jun 24, 2026
Why The OrthoPediatrics (KIDS) Narrative Is Evolving Without A New Price Target
Simply Wall St. · Jun 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About OrthoPediatrics Corp.
OrthoPediatrics Corp. is led by CEO David R. Bailey, publicly traded since 2017.
OrthoPediatrics Corp. (KIDS) stock trades at $21.76 with a market capitalization of $558.91M. The stock is valued at a price-to-earnings (P/E) ratio of -13.19, price-to-book of 1.54, price-to-sales of 2.25. Over the past 52 weeks the stock has ranged between $14.42 and $26.74, and currently trades 18.6% below its 52-week high.
On profitability, OrthoPediatrics Corp. generates a return on equity (ROE) of -11.53%, return on capital employed of -4.97%, an operating margin of -12.29%, a net profit margin of -15.72%.